Q J Med 2003; 96: 731-738
© 2003 Association of Physicians
Lymphoedema: an underestimated health problem
From the 1Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University, London, 2St George’s Hospital Medical School, London, 3The Haven Trust, London, 4Department of Bio-engineering, Imperial College, London, UK
Received 20 January 2003 and in revised form 7 August 2003
Background: Lymphoedema/chronic oedema is an important cause of morbidity in the population, but little is known of its epidemiology and impact on patients or health services.
Aim: To determine the magnitude of the problem of chronic oedema in the community, and the likely impact of oedema on use of health resources, employment and patient’s quality of life.
Design: Questionnaire-based survey.
Methods: Health professionals from dedicated lymphoedema services, specific out-patient clinics, hospital wards and community services (GP clinics and district nurses) were contacted to provide information on patients from within South West London Community Trust. A subset of the identified patients was interviewed.
Results: Within the catchment area, 823 patients had chronic oedema (crude prevalence 1.33/1000). Prevalence increased with age (5.4/1000 in those aged > 65 years), and was higher in women (2.15 vs. 0.47/1000). Only 529 (64%) were receiving treatment, despite two specialist lymphoedema clinics within the catchment area. Of 228 patients interviewed, 78% had oedema lasting > 1 year. Over the previous year, 64/218 (29%) had had an acute infection in the affected area, 17/64 (27%) being admitted for intravenous antibiotics. Mean length of stay for this condition was 12 days, estimated mean cost £2300. Oedema caused time off work in > 80%, and affected employment status in 9%. Quality of life was below normal, with 50% experiencing pain or discomfort from their oedema.
Discussion: Chronic oedema is a common problem in the community with at least 100 000 patients suffering in the UK alone, a problem poorly recognized by health professionals. Lymphoedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.
Address correspondence to Professor C.J. Moffatt, Centre for Research and Implementation of Clinical Practice, Faculty of Health & Human Sciences, Thames Valley University, 32–38 Uxbridge Road, London W5 2BS. e-mail: christine.moffatt{at}tvu.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-C. T. Shih, Y. Xu, J. N. Cormier, S. Giordano, S. H. Ridner, T. A. Buchholz, G. H. Perkins, and L. S. Elting Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study J. Clin. Oncol., April 20, 2009; 27(12): 2007 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Rockson Diagnosis and Management of Lymphatic Vascular Disease J. Am. Coll. Cardiol., September 2, 2008; 52(10): 799 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Bogan, J. M. Powell, and B. J. Dudgeon Experiences of Living With Non-Cancer-Related Lymphedema: Implications for Clinical Practice Qual Health Res, February 1, 2007; 17(2): 213 - 224. [Abstract] [PDF]
|
|
|
|
 |
|
 A. F Williams, P. J Franks, and C. J Moffatt Lymphoedema: estimating the size of the problem Palliative Medicine, June 1, 2005; 19(4): 300 - 313. [Abstract] [PDF]
|
|